Company intelligence / Profile preview

KYLYS AESTHETICS

Plan-les-Ouates, Geneva, Switzerlandkylysaesthetics.com ↗

Ownership: Private
Employees: ~3
Development stage: Other

Overview

KYLYS AESTHETICS has developed a patented, biocompatible, thermosensitive hyaluronan-based dermal filler that forms microgel structures in tissue. This results in long-lasting effects with no migration from the injection site. The product can be injected with an ultra-thin needle for greater precision and less pain. All preclinical tests have been completed, GMP production is underway, and the company is preparing its first pilot clinical trial.

Therapeutic areas: Dermatology
Modalities: BiologicHyaluronic acid-based gelMedical device (dermal filler)
Industry: Implantable Medical Devices

Partnerships

Innosuisse project collaboration for prototype development

Beyond the preview

Go deeper on KYLYS AESTHETICS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KYLYS AESTHETICS.

Explore the full profile